Comparing Parallel Surrogate-based and Surrogate-free Multi-Objective Optimization of COVID-19 vaccines allocation - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

Comparing Parallel Surrogate-based and Surrogate-free Multi-Objective Optimization of COVID-19 vaccines allocation

Résumé

The simulation-based and computationally expensive problem tackled in this paper addresses COVID-19 vaccines allocation in Malaysia. The multi-objective formulation considers simultaneously the total number of deaths, peak hospital occupancy and relaxation of mobility restrictions. Evolutionary algorithms have proven their capability to handle multi-to-many objectives but require a high number of computationally expensive simulations. The available techniques to raise the challenge rely on the joint use of surrogate-assisted optimization and parallel computing to deal with computational expensiveness. On the one hand, the simulation software is imitated by a cheap-to-evaluate surrogate model. On the other hand, multiple candidates are simultaneously assessed via multiple processing cores. In this study, we compare the performance of recently proposed surrogate-free and surrogate-based parallel multi-objective algorithms through the application to the COVID-19 vaccine distribution problem.
Fichier principal
Vignette du fichier
camera_ready_g_briffoteaux_et_al.pdf (6.61 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03689674 , version 1 (07-06-2022)

Identifiants

  • HAL Id : hal-03689674 , version 1

Citer

Guillaume Briffoteaux, Romain Ragonnet, Pierre Tomenko, Mohand Mezmaz, Nouredine Melab, et al.. Comparing Parallel Surrogate-based and Surrogate-free Multi-Objective Optimization of COVID-19 vaccines allocation. OLA 2022 - International Conference on Optimization and Learning, Jul 2022, Syracuse, Italy. ⟨hal-03689674⟩
276 Consultations
23 Téléchargements

Partager

Gmail Facebook X LinkedIn More